NDC 0143-9574-01 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9574
- Requested NDC
- 0143-9574-01
- Package NDCs from labels
- 0143-9574-01, 0143-9574-10, 0143-9574-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2025-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| WATER - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2025-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9574-01 | Levetiracetam | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 5 | 12 | |
| 0143-9574-10 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 12 | |
| 0143-9574-25 | Levetiracetam | 25 in 1 CARTON | INJECTION | 25 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9574-01 | ML - Milliliter | 0143-9574 | a76b42f4-7d32-40c2-b6bf-cbd6e72f8870 | 1 | 2015-08-04 |
| 0143-9574-10 | ML - Milliliter | 0143-9574 | 14569afe-3337-4b39-a78b-89e0ee21517e | 1 | 2015-08-04 |
| 0143-9574-25 | ML - Milliliter | 0143-9574 | 6ab6fbc7-52bb-4c39-80f2-c82479ab8c5c | 1 | 2017-03-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 3 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 3 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | LEVETIRACETAM INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 3 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | LEVETIRACETAM INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | LEVETIRACETAM INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LEVETIRACETAM INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| D-88 | COCCULUS INDICUS, NATRUM MURIATICUM, HELONIAS DIOICA, CALCAREA PHOSPHORICUM, IGNATIA AMARA, MAGNESIA PHOSPHORICUM, CIMICIFUGA RACEMOSA, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, SEPIA, KALIUM PHOSPHORICUM, ZINCUM METALLICUM, PITUITARY, ADRENAL, OVARIAN | DNA Labs, Inc. | 1eefff9c-d86c-44ef-b968-9a8c5a9c5403 | 2025-01-13 | Warnings | 451W47IQ8X |
| D-133 | CALCIUM FLUORIDE, SILICON DIOXIDE, TRIBASIC CALCIUM PHOSPHATE, CALCIUM SULFATE ANHYDROUS, FERROSOFERRIC PHOSPHATE, POTASSIUM CHLORIDE, DIBASIC POTASSIUM PHOSPHATE, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM CHLORIDE, AND SODIUM SULFATE | DNA Labs, Inc. | a250b7e9-7fd2-4cb0-82f3-baa089d17441 | 2025-01-13 | Warnings | 451W47IQ8X |
| Premixed saline packets | SODIUM CHLORIDE, SODIUM BICARBONATE | Shenzhen Kerui lntl Trading Co., Ltd | 0d11e07b-c137-6efc-e063-6394a90a6bba | 2025-01-09 | Warnings | 451W47IQ8X |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2b9456-8ca0-8253-e053-2a95a90a8f12 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2a34f9-ed95-9921-e053-2995a90a0d59 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2bc45d-e0c8-3af2-e053-2a95a90af0f1 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67169d-6b15-3406-e053-2995a90a60e4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a673225-27be-040a-e053-2a95a90a0a98 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66b61d-82bd-2bbb-e053-2995a90a0b58 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a677063-09d2-8052-e053-2a95a90affae | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a678fac-289c-0f5c-e053-2995a90a0f43 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66da0b-ee7b-2b69-e053-2995a90ae951 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a667d80-d05c-2d18-e053-2995a90a2918 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66e2a9-a661-e847-e053-2a95a90aa304 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67a0bb-6943-2f5f-e053-2a95a90aac6e | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a6711a9-e0a4-9083-e053-2a95a90ad4a4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67bb27-cb44-4a1d-e053-2a95a90a0ee2 | 2025-01-09 | Q40Q9N063P | |
| STERILE WATER | STERILE WATER | HF Acquisition Co. LLC, DBA HealthFirst | 74ed2a6f-824c-a1ff-e053-2a91aa0a57c0 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 77bd3c0f-f4ab-7cfa-e053-2a91aa0a1b83 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.